125 related articles for article (PubMed ID: 38452616)
41. CYP2C9, a Metabolic CYP450s Enzyme, Plays Critical Roles in Activating Ellagic Acid in Human Intestinal Epithelial Cells.
Gu Y; Hou W; Shen XY; Zhuo SX; Zhang HR; Ji MH; Chen MJ; Guo YY
Med Sci Monit; 2020 May; 26():e923104. PubMed ID: 32453717
[TBL] [Abstract][Full Text] [Related]
42. The Effects of AT-533 and AT-533 gel on Liver Cytochrome P450 Enzymes in Rats.
Wu Y; Li M; Guo Y; Liu T; Zhong L; Huang C; Ye C; Liu Q; Ren Z; Wang Y
Eur J Drug Metab Pharmacokinet; 2022 May; 47(3):345-352. PubMed ID: 35137361
[TBL] [Abstract][Full Text] [Related]
43. Effects of dibutyl phthalate and di(2-ethylhexyl) phthalate with their metabolites on CYP2C9*1 and CYP2C19*1 activities in vitro.
Chen B; Hu X; Zhen X; Hu GX
J Pharm Biomed Anal; 2018 Oct; 160():195-201. PubMed ID: 30099291
[TBL] [Abstract][Full Text] [Related]
44. Metabolic characterization of the major human small intestinal cytochrome p450s.
Obach RS; Zhang QY; Dunbar D; Kaminsky LS
Drug Metab Dispos; 2001 Mar; 29(3):347-52. PubMed ID: 11181505
[TBL] [Abstract][Full Text] [Related]
45. In Vivo Gene Expression Profile of Human Intestinal Epithelial Cells: From the Viewpoint of Drug Metabolism and Pharmacokinetics.
Takayama K; Ito K; Matsui A; Yamashita T; Kawakami K; Hirayama D; Kishimoto W; Nakase H; Mizuguchi H
Drug Metab Dispos; 2021 Mar; 49(3):221-232. PubMed ID: 33384384
[TBL] [Abstract][Full Text] [Related]
46. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.
Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK
Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607
[TBL] [Abstract][Full Text] [Related]
47. Contribution of the human cytochrome P450 2C subfamily to the metabolism of and the interactions with endogenous compounds including steroid hormones.
Niwa T; Yasuda S; Yamamoto Y; Murakami M; Ishii R
Pharmazie; 2021 Dec; 76(12):611-613. PubMed ID: 34986958
[TBL] [Abstract][Full Text] [Related]
48. Successful Prediction of Human Pharmacokinetics After Oral Administration by Optimized Physiologically Based Pharmacokinetics Approach and Permeation Assay Using Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells.
Mayumi K; Akazawa T; Kanazu T; Ohnishi S; Hasegawa H
J Pharm Sci; 2020 Apr; 109(4):1605-1614. PubMed ID: 31884012
[TBL] [Abstract][Full Text] [Related]
49. Similar substrate specificity of cynomolgus monkey cytochrome P450 2C19 to reported human P450 2C counterpart enzymes by evaluation of 89 drug clearances.
Hosaka S; Murayama N; Satsukawa M; Uehara S; Shimizu M; Iwasaki K; Iwano S; Uno Y; Yamazaki H
Biopharm Drug Dispos; 2015 Dec; 36(9):636-43. PubMed ID: 26348733
[TBL] [Abstract][Full Text] [Related]
50. Genetic Polymorphisms and in Vitro Functional Characterization of CYP2C8, CYP2C9, and CYP2C19 Allelic Variants.
Hiratsuka M
Biol Pharm Bull; 2016; 39(11):1748-1759. PubMed ID: 27803446
[TBL] [Abstract][Full Text] [Related]
51. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.
Yousef AM; Bulatova NR; Newman W; Hakooz N; Ismail S; Qusa H; Zahran F; Anwar Ababneh N; Hasan F; Zaloom I; Khayat G; Al-Zmili R; Naffa R; Al-Diab O
Mol Biol Rep; 2012 Oct; 39(10):9423-33. PubMed ID: 22722998
[TBL] [Abstract][Full Text] [Related]
52. Generation of Intestinal Organoids Suitable for Pharmacokinetic Studies from Human Induced Pluripotent Stem Cells.
Onozato D; Yamashita M; Nakanishi A; Akagawa T; Kida Y; Ogawa I; Hashita T; Iwao T; Matsunaga T
Drug Metab Dispos; 2018 Nov; 46(11):1572-1580. PubMed ID: 29615438
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of Potential Drug-Drug Interaction Risk of Pexidartinib With Substrates of Cytochrome P450 and P-Glycoprotein.
Zahir H; Kobayashi F; Zamora C; Gajee R; Gordon MS; Babiker HM; Wang Q; Greenberg J; Wagner AJ
J Clin Pharmacol; 2021 Mar; 61(3):298-306. PubMed ID: 32918831
[TBL] [Abstract][Full Text] [Related]
54. The development of a functional human small intestinal epithelium model for drug absorption.
Kwon O; Jung KB; Lee KR; Son YS; Lee H; Kim JJ; Kim K; Lee S; Song YK; Jung J; Park K; Kim DS; Son MJ; Lee MO; Han TS; Cho HS; Oh SJ; Chung H; Kim SH; Chung KS; Kim J; Jung CR; Son MY
Sci Adv; 2021 Jun; 7(23):. PubMed ID: 34078609
[TBL] [Abstract][Full Text] [Related]
55. Efficient Generation of Cynomolgus Monkey Induced Pluripotent Stem Cell-Derived Intestinal Organoids with Pharmacokinetic Functions.
Onozato D; Yamashita M; Fukuyama R; Akagawa T; Kida Y; Koeda A; Hashita T; Iwao T; Matsunaga T
Stem Cells Dev; 2018 Aug; 27(15):1033-1045. PubMed ID: 29742964
[TBL] [Abstract][Full Text] [Related]
56. Simultaneous Evaluation of Membrane Permeability and UDP-Glucuronosyltransferase-Mediated Metabolism of Food-Derived Compounds Using Human Induced Pluripotent Stem Cell-Derived Small Intestinal Epithelial Cells.
Kitaguchi T; Mizota T; Ito M; Ohno K; Kobayashi K; Ogawa I; Qiu S; Iwao T; Hanioka N; Tanaka M; Matsunaga T
Drug Metab Dispos; 2022 Jan; 50(1):17-23. PubMed ID: 34670778
[TBL] [Abstract][Full Text] [Related]
57. Human intestinal organoid-derived PDGFRα + mesenchymal stroma enables proliferation and maintenance of LGR4 + epithelial stem cells.
Chen J; Horiuchi S; Kuramochi S; Kawasaki T; Kawasumi H; Akiyama S; Arai T; Morinaga K; Kimura T; Kiyono T; Akutsu H; Ishida S; Umezawa A
Stem Cell Res Ther; 2024 Jan; 15(1):16. PubMed ID: 38229108
[TBL] [Abstract][Full Text] [Related]
58. MiR-155 and other microRNAs downregulate drug metabolizing cytochromes P450 in inflammation.
Kugler N; Klein K; Zanger UM
Biochem Pharmacol; 2020 Jan; 171():113725. PubMed ID: 31758923
[TBL] [Abstract][Full Text] [Related]
59. Effect of GLPG1205, a GPR84 Modulator, on CYP2C9, CYP2C19, and CYP1A2 Enzymes: In Vitro and Phase 1 Studies.
Desrivot J; Van Kaem T; Allamassey L; Helmer E
Clin Pharmacol Drug Dev; 2021 Sep; 10(9):1007-1017. PubMed ID: 33955686
[TBL] [Abstract][Full Text] [Related]
60. Multigene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19, and ABCB1.
Powers JL; Buys SS; Fletcher D; Melis R; Johnson-Davis KL; Lyon E; Malmberg EM; McMillin GA
J Clin Pharmacol; 2016 Dec; 56(12):1570-1581. PubMed ID: 27198207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
